• search
Country
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
In vitro ADME

In vitro ADME

In vitro ADME assays catering to every stage of drug discovery; standalone studies and customized assays.

We have more than 16 years of experience in ADME drug discovey services. We have validated ADME assays in place, amenable to customized study design as per customer requirement. Our expert team of scientists cater to the ADME requirements with unparalleled troubleshooting abilities. We have experience in handling small molecules, therapeutic peptides and complex molecules.

Speak to our experts

Physiochemical Properties

Solubility and chemical stability at different pH, SIF and SGF

Solubility: Kinetic, thermodynamic, HT Log D

Permeability

Caco-2 Bi-directional permeability, Efflux ratio MDCK, MDCK-LE, MDCK-MDR1, MDCK-BCRP permeability PAMPA

Distribution

Plasma Protein, in vitro Tissue binding

Blood to plasma partition

Brain to plasma partition

Metabolism

Microsomal Clearance, S9, Phase I/Phase II, Hepatocyte Clearance

Plasma/ Whole Blood Stability CYP Phenotyping

Drug-Drug Interactions

CYP Inhibition, CYP TDI, kobs

CYP Induction

P-gp and BCRP Inhibition & Substrate Identification

Why Aurigene Pharmaceutical Services?

Quick turnaround time: In vitro Assays: 5 working days

High throughput (96-well plate) assays

Unidirectional and bidirectional permeability

Highly-experienced and expert team of scientists

Virtual Tour

 

Contact Us

Country
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
resourceMainImage

JUNE 28, 2022

Neoantigen Specific T cells For Cancer Immunotherapy

Neoantigen specific T cells for cellular cancer immunotherapy An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence...

Read More
resourceMainImage

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization Maximizing efficiency in drug research, development, and manufacturing is crucial for turning new innovations into therapeutic and financial benefits. Over the past couple of decades, pharmaceutical companies have increasingly turned to contr...

Read More
resourceMainImage

Technology meets sustainability - How a complex API development process goes green

We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more. ...

Read More

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug

2023

Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack